Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 25 | 24 | −1 |
| Shares | 887.5K | 804.0K | −83.5K (−9.4%) |
| Value | $5.10M | $4.28M | −$819.0K (−16.1%) |
New holders (3)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 16,642 | $88.5K | 0.00% |
| Shay Capital LLC | 15,958 | $84.9K | 0.02% |
| DRW Securities, LLC | 12,322 | $65.6K | 0.00% |
Sold out (4)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| ADAR1 Capital Management, LLC | 10,823 | $62.4K |
| GWM Advisors LLC | 483 | $2.79K |
| FMR LLC | 121 | $705 |
| Danske Bank A/S | 1 | $6 |